Clear all filters Results are currently filtered by:
22 January 2020
The Pharmacy Guild of Australia thanks outgoing Secretary of the Department of Health Glenys Beauchamp for her service and commitment to the sector.
14 January 2020
The South Australian Branch of the Pharmacy Guild of Australia welcomes the decision of the State Government to expand the ability of pharmacists to dispense medicines without prescription to patients affected by the Kangaroo Island bushfires.
13 January 2020
The Pharmacy Guild of Australia has welcomed the extension of continued dispensing arrangements to ensure that bushfire affected patients continue to have subsidised access to Pharmaceutical Benefits Scheme medicines.
10 January 2020
The Guild has today received this advice from the ACT Government. A temporary Standing Order has been issued by the ACT Chief Health Officer, Dr Kerryn Coleman to enable supply of designated prescription only medicines by pharmacists without a prescription,…
9 January 2020
The Pharmacy Guild of Australia sought advice from Guild Insurance to provide to Members who are operating in bushfire affected areas.
9 January 2020
The Pharmacy Guild of Australia welcomes the announcement made by the Victorian Minister of Health Jenny Mikakos MP that enables Victorian pharmacists to dispense prescription-only medicines to people impacted by bushfires until 1 April 2020.The authority allows all pharmacists registered…
8 January 2020
A temporary special authority has been issued by the NSW Chief Health Officer until 31 March 2020 for supply of prescription medicines from a community pharmacy in emergencies in a bushfire affected area in NSW. The usual arrangements for 3…
7 January 2020
Former Kmart CEO, Guy Russo, who has been credited with one of Australia’s most successful business turnarounds, will offer in-depth insights and advice to pharmacists on how he transformed Kmart into one of the most popular and profitable retail businesses…
6 January 2020
The Guild has now received confirmed price changes from the Government for 1 February 2020.
19 December 2019
Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, has experienced manufacturing challenges that have resulted in interruptions in the production of EpiPen® Jr 150 mcg Adrenaline (epinephrine) Auto-Injectors.